Fujitsu Laboratories Ltd. announced development of a technology to retrieve similar disease cases from a computed tomography (CT) database of previously taken images. The technology, jointly developed with Fujitsu R&D Center Co. Ltd., works by retrieving similar cases of abnormal shadows expanding in a three-dimensional manner.
June 26, 2017 — Fujifilm Medical Systems U.S.A. Inc. announced that its Synapse PACS (picture archiving and communication system) line has been granted Authority to Operate (ATO) on networks in the U.S. Department of Defense (DoD). The announcement makes Fujifilm the first vendor with a networked medical system to attain a Risk Management Framework (RFM)-based ATO.
June 26, 2017 — A recent study appears to confirm the recommendations of the National Comprehensive Cancer Network (NCCN) Guidelines panel against chest computed tomography (CT) scans in breast cancer patients asymptomatic for distant metastases. The study, conducted by researchers at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, is published in the June issue of Journal of the National Comprehensive Cancer Network (JNCCN).
Medidata and Median Technologies announced a new collaboration to streamline the growth and use of medical imaging in cancer clinical trials. Median Technologies will leverage the Medidata Clinical Cloud to accelerate the development of medicines in oncology with new, scalable image management services.
RamSoft announced a new partnership with Peru-based medical imaging equipment provider, Gamel. With RamSoft’s PowerServer RIS/PACS (radiology information system/picture archiving and communication system) and Gateway Viewer Mini PACS, Gamel’s clients will benefit from improved service accuracy, increased patient turnaround times and optimal patient care.
June 23, 2017 — French radiology technology company Therapixel was recently named the winner of the Digital Mammography Challenge for their artificial intelligence algorithm designed to enhance mammography reading.
The American Society for Radiation Oncology (ASTRO) recently issued a new clinical guideline for the use of stereotactic body radiation therapy (SBRT) in early-stage lung cancer. While SBRT is the current standard of care for peripherally located tumors in patients who cannot undergo surgery, the new guideline addresses the appropriateness of SBRT for medically inoperable patients with high-risk clinical scenarios requiring curative focused therapy. The guideline also reviews the role of SBRT for centrally located tumors because of their unique risks compared to peripheral tumors.
If you enjoy this content, please share it with a colleague
June 22, 2017 — Riverain Technologies announced that it is now processing data from nearly 50 computed tomography (CT) scanners that include all major manufacturers with its ClearRead CT technology. The company said this includes leading centers such as Duke University Medical Center, Saint Luke’s Kansas City, Einstein Medical Center, University of Maryland and the University of Michigan.
A new article published by JAMA Oncology compares outcomes for combined mammography and magnetic resonance imaging (MRI) or ultrasonography screenings for new breast cancers in women who have previously undergone breast conservation surgery and radiotherapy for breast cancer initially diagnosed at 50 or younger.
